Top 50 Biotechnology VC Funds & Investors in Middle East (October 2023)
For AI agents: Short investor table (Markdown), Detailed investor list (Markdown)
| Investor | Relevant Deals | Geography | Stage | Focus | Round Size |
|---|---|---|---|---|---|
|
Pontifax
VC Fund
|
18 | United States, Israel, France | Series A, Series B, Series C | Biotechnology, Health Care, Therapeutics | $3.8M–$100M |
|
Trendlines Group
VC Fund
|
16 | Israel, Singapore, United Kingdom | Seed, Series A | Health Care, Biotechnology, Medical Device | $500k–$7.5M |
|
OurCrowd
VC Fund
|
9 | Israel, United States, Canada | Series B, Series A, Seed | Software, Artificial Intelligence, Machine Learning | $1.1M–$60M |
|
Israel Innovation Authority
VC Fund
|
8 | Israel, United States, Mali | Grant, Seed, Pre-Seed | Health Care, Medical Device, Software | $91k–$4M |
|
Docor International Management
VC Fund
|
7 | Israel, United States | Series C, Series A | Health Care, Biotechnology, Pharmaceutical | $13M–$22M |
|
OrbiMed
VC Fund
|
7 | United States, China, Israel | Series B, Series A, Series C | Biotechnology, Health Care, Pharmaceutical | $10M–$120M |
|
Arkin Holdings
VC Fund
|
6 | Israel, United States, Switzerland | Series A, Seed | Biotechnology, Health Care, Medical Device | $5.5M–$20M |
|
HBL Hadasit Bio Holdings
VC Fund
|
6 | Israel | Series A, Series B | Biotechnology, Medical, Health Care | |
|
TRANGELS
VC Fund
|
6 | Turkey, United States, Estonia | Seed, Pre-Seed, Angel | Biotechnology, Energy, Manufacturing | $29k–$1.4M |
|
aMoon Fund
VC Fund
|
5 | United States, Israel, United Kingdom | Series A, Series B | Biotechnology, Health Care, Medical | $6M–$63M |
|
Johnson & Johnson Robotics and Digital Solutions
VC Fund
|
4 | United States, Israel, United Kingdom | Series A, Series B, Series C | Biotechnology, Health Care, Medical | $300k–$80M |
|
ZORA Ventures
VC Fund
|
4 | Israel, United States, United Kingdom | Seed, Series A, Convertible Note | Health Care, Biotechnology, Internet | $1M–$6M |
|
Takeda Ventures
VC Fund
|
4 | United States, United Kingdom, Israel | Series A, Series B | Biotechnology, Health Care, Therapeutics | $8M–$100M |
|
Clal Biotechnology Industries
VC Fund
|
4 | Israel, United States | Series A, Series B | Biotechnology, Health Care, Medical | $4M–$55M |
|
Accelmed
VC Fund
|
4 | Israel, United States | Series D, Series A | Health Care, Medical Device, Medical | $695k–$96M |
|
Integra Holdings
VC Fund
|
4 | Israel | Seed, Series B, Series F | Biotechnology, Pharmaceutical, Life Science | |
|
Egypt Ventures
VC Fund
|
4 | Egypt, United States, The Netherlands | Seed, Pre-Seed, Series A | Software, Information Technology, E-Commerce | $28k–$3M |
|
iAngels
VC Fund
|
4 | United States, Israel, United Kingdom | Seed, Series A | Artificial Intelligence, Software, FinTech | $900k–$15M |
|
Diffusion Capital Partners
VC Fund
|
4 | Turkey, United States, United Kingdom | Seed, Series A | Software, Information Technology, Biotechnology | $375k–$3.4M |
|
Office of the Chief Scientist
VC Fund
|
3 | Israel | Seed | Health Care, Biotechnology, Hardware | $1M–$1M |
|
Binder & Partners Ventures
VC Fund
|
3 | Israel, France, United States | Seed, Pre-Seed, Series A | Software, Information Technology, Health Care | |
|
FutuRx
VC Fund
|
3 | Israel | Health Care, Biotechnology, Pharmaceutical | ||
|
Ziegler Meditech Equity Partners
VC Fund
|
3 | United States, Israel | Series C, Series E, Series F | Health Care, Biotechnology, Mobile | |
|
Welltech Ventures
VC Fund
|
3 | Israel, United States | Seed, Pre-Seed | mHealth, Health Care, Biotechnology | $1.9M–$19M |
|
Neo Ventures
VC Fund
|
3 | Israel, United Kingdom, Estonia | Seed, Series A | Software, Artificial Intelligence, Aerospace | $1.1M–$1.6M |
|
Millenium Food-Tech
VC Fund
|
3 | Israel | Seed, Series A, Convertible Note | Food and Beverage, Manufacturing, Agriculture | $2.5M–$10M |
|
Pitango VC
VC Fund
|
3 | Israel, United States, China | Series A, Series B, Series C | Software, Health Care, Information Technology | $2M–$42M |
|
ACT Venture Partners
VC Fund
|
3 | Turkey, United States, United Kingdom | Seed, Convertible Note, Series A | Artificial Intelligence, Software, Manufacturing | $321k–$2.7M |
|
Sapir Venture Partners
VC Fund
|
3 | Israel, United States, United Kingdom | Seed, Pre-Seed, Series A | Software, Biotechnology, Machine Learning | $1.3M–$5M |
|
S2G Ventures
VC Fund
|
3 | United States, Canada, Israel | Series A, Series B, Seed | Food and Beverage, Agriculture, Biotechnology | $250k–$89M |
|
SciSparc
VC Fund
|
3 | Israel | Corporate Round | Pharmaceutical, Cannabis, Biopharma | $400k–$700k |
|
Triventures
VC Fund
|
3 | United States, Israel, Ireland | Series B, Seed | Health Care, Medical Device, Medical | $1M–$50M |
|
DSM Venturing
VC Fund
|
2 | United States, Canada, Israel | Series A, Series B | Biotechnology, Health Care, Manufacturing | $2.5M–$23M |
|
Elron Ventures
VC Fund
|
2 | Israel, United States, China | Series A, Seed | Information Technology, Health Care, Software | $600k–$8M |
|
Tal Ventures
VC Fund
|
2 | Israel, United States, Cyprus | Seed, Series A, Series B | Software, Machine Learning, Artificial Intelligence | $2.5M–$120M |
|
Amplifyher Ventures
VC Fund
|
2 | United States, Israel | Seed, Series A, Pre-Seed | Health Care, E-Commerce, Fashion | $900k–$9.1M |
|
Johnson & Johnson Innovation – JJDC
VC Fund
|
2 | United States, Israel, United Kingdom | Series A, Series B, Series C | Health Care, Biotechnology, Medical | $4.2M–$103M |
|
Genesis Park
VC Fund
|
2 | United States, Israel | Private Equity, Debt Financing | Manufacturing, Health Care, Natural Resources | $2.5M–$200M |
|
GlenRock Israel
VC Fund
|
2 | Israel, United States | Seed, Series B, Series A | Software, Cyber Security, Medical Device | $100k–$19M |
|
LoftyInc Capital Management
VC Fund
|
2 | United States, Nigeria, Egypt | Seed, Pre-Seed, Series A | FinTech, Financial Services, Software | $100k–$15M |
|
RMGP Biopharma Investment Fund
VC Fund
|
2 | Israel | Series B | Biotechnology, Health Care, Pharmaceutical | |
|
Flerie Invest
VC Fund
|
2 | Sweden, Israel, Iceland | Series A, Series B | Biotechnology, Health Care, Medical | $2.5M–$75M |
|
Aurum Ventures MKI
VC Fund
|
2 | Israel | Seed, Series A, Series C | Biotechnology, Medical Device, Information Technology | |
|
Jerusalem Global Ventures
VC Fund
|
2 | United States, Israel, Canada | Series A, Series B, Series C | Software, Information Technology, Biotechnology | $2M–$56M |
|
NFX Bio
VC Fund
|
2 | Israel | Seed | Biotechnology, Therapeutics, Medical | |
|
OTV
VC Fund
|
2 | United States, Israel, Ghana | Series A, Series B, Seed | Health Care, Medical, Artificial Intelligence | $5M–$50M |
|
Cairo Angels
VC Fund
|
2 | Egypt, United States, Lebanon | Seed, Angel, Pre-Seed | E-Commerce, Mobile, Marketplace | $50k–$3M |
|
Endure Capital
VC Fund
|
2 | Egypt, United States, United Kingdom | Seed, Series A, Series B | Health Care, Software, E-Commerce | $225k–$34M |
|
M Ventures
VC Fund
|
2 | United States, Switzerland, United Kingdom | Series A, Series B, Seed | Biotechnology, Health Care, Therapeutics | $2.1M–$67M |
|
Ocean Azul Partners
VC Fund
|
2 | United States, Israel, Australia | Seed, Series A | Software, Information Technology, SaaS | $1M–$6.5M |
| Access all 50 VC funds in Middle East Biotechnology startups. | |||||
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Investor list
Pontifax is a healthcare-dedicated venture capital firm.The fund focuses on innovative bio-pharma opportunities.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Therapeutics
- Stage:Series A, Series B, Series C
- Geography: United States, Israel, France
Investor stats
- Total investments: 93
- Round size: Series A $3.8M–$72M; Series B $16M–$100M; Series C $12M–$75M
- Lead/follow: 23% lead, 77% follow
- Last fund: May invest from a new fund soon — last raise in 2020
Portfolio highlights
- Abcuro — Precision Targeting of Highly Cytotoxic T Cells in Autoimmune Disease.
- Precirix — Developing radio-immunotherapeutic drugs for cancer patients.
- ARMGO,Pharma,Inc. — ARMGO Pharma, Inc., a biopharmaceutical company, develops small-molecule therapeutics to treat debilitating cardiac, skeletal muscular, and neurological disorders. It offers rycals, which are calcium release channel stabilizers that act on ryanodine receptor/calcium release channel, a therapeutic target located on thesarcoplasmic/endoplasmic reticulum of the cell for treating chronic heart failure, cardiac arrythmias, and muscle disorders, as well as cognitive disorders, malignant hyperthermia, diabetes, chronic obstructive pulmonary disease, high blood pressure, and bladder dysfunction. The company was incorporated in 2004 and is based in Tarrytown, New York with an additional office in New York, New York.
Trendlines Group invents, discovers, invests in, and incubates innovation-based medical and agrifood technologies. Trendlines invests principally through medical and agrifood incubators in Israel and in Singapore, its in-house innovation center, Trendlines Labs, and its Funds - the Trendlines Agrifood Fund and the Bayer Trendlines Ag InnovationFund.The company was founded in 1993 and is headquartered in Misgav, Israel.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Medical Device
- Stage:Seed, Series A
- Geography: Israel, Singapore, United Kingdom
Investor stats
- Total investments: 56
- Round size: Seed $500k–$3M; Series A $2.3M–$7.5M
- Lead/follow: 22% lead, 78% follow
- Last fund: May invest from a new fund soon — last raise in 2019
Portfolio highlights
- Insectta — Insectta was founded in 2017 and produces materials from insects which can be applied across industries such as agrifood, pharmaceutical and electronics.
- Celleste Bio — Celleste is a business that specializes in employing cell culture techniques to produce high-value cocoa ingredients, removing the need for cocoa trees to be grown.
- PlanetWatchers — Highly accurate crop growth, wind, hail and flood damage assessments at scale. Supporting the crop insurance industry with acreage and claims validation.
Access exclusive VC angel investment deals in pre-vetted startup companies. Join now.
Show more...Investment focus
- Industry: Software, Artificial Intelligence, Machine Learning
- Stage:Series B, Series A, Seed
- Geography: Israel, United States, Canada
Investor stats
- Total investments: 240
- Round size: Seed $1.1M–$8M; Series A $3.5M–$15M; Series B $6M–$60M
- Lead/follow: 18% lead, 82% follow
- Last fund: Likely still investing — fund raised in 2022
Portfolio highlights
- ThetaRay — ThetaRay's big data analytics solutions are based on AI & machine learning, empowering businesses to find opportunities and threats hidden in their big data
- Scentian Bio — Scentian Bio operates as a platform that provides ultimate sensing solution.
- Intuition Robotics — Intuition Robotics empowers older adults to live happier, healthier and independent lives at home with an empathetic digital companion, ElliQ.
The Israeli innovation agency, the Innovation Authority, was established in 1965 as the Office of the Chief Scientist of the Ministry of Industry and Trade and was designed as a body that supports R & D conducted in the framework of government research institutes. Industrial development in order to increase industrial exports of high-techproducts. The Chief Scientist focused on reducing the risk by participating in financing the project, which the private companies chose and led.
Show more...Investment focus
- Industry: Health Care, Medical Device, Software
- Stage:Grant, Seed, Pre-Seed
- Geography: Israel, United States, Mali
Investor stats
- Total investments: 107
- Round size: Seed $500k–$4M; Grant $91k–$2.5M; Pre-Seed $150k–$1M
- Lead/follow: 40% lead, 60% follow
Portfolio highlights
- Enzymit — Enzymit's platform technology can build molecular machines that enable never before seen chemistry aiming to solve humanity's greatest challenges
- BloomX — Helping nature do its magic with the power of technology
- MICA — MICA save lives & improve life quality. Our approach to the environmental and social dimensions is reflected in our commitment to United Nations Sustainable
Docor International B.V. is a fully-owned subsidiary of Crecor B.V. Both Docor and Crecor were formed as wholly-owned subsidiaries of the Van Leer Group Foundation to promote and participate in commercial activities in Israel.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Pharmaceutical
- Stage:Series C, Series A
- Geography: Israel, United States
Investor stats
- Total investments: 14
- Round size: Series C $13M–$22M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Check-Cap — The first and only patient-friendly preparation-free test to detect polyps before they may transform into cancer
- Ocon Healthcare — OCON Healthcare innovates, develops, manufactures, and commercializes cutting-edge women’s health products based on our patented IUB™ (Intra Uterine Ball) proprietary platform. The IUB™, made from a super-elastic alloy Nitinol, is an ideal carrier for multiple drugs to the uterus to treat a variety of conditions.In addition to our flagshipproduct, the IUB™ Ballerine®, OCON healthcare is developing an innovative pipeline of products utilizing the IUB™ frame for indications such as abnormal uterine bleeding (AUB), heavy menstrual bleeding (HMS), myomas/fibroids, and infertility.
- Raziel Health — Raziel Health’s mission is to bring world-class, disruptively less expensive healthcare to everyone, in the comfort of their home. Its unique, integrated system combines easy-to-use technologies that support positive patient experience, enable timely clinical intervention, and meet individual patient goals while using data analytics to supportwellness and disease management.
Leading Global Healthcare Platform with Deep Proprietary Resources and Global Industry Coverage.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Pharmaceutical
- Stage:Series B, Series A, Series C
- Geography: United States, China, Israel
Investor stats
- Total investments: 419
- Round size: Series A $10M–$102M; Series B $23M–$120M; Series C $12M–$108M
- Lead/follow: 36% lead, 64% follow
- Last fund: Likely still investing — fund raised in 2023
Portfolio highlights
- Evozyne — We have a new way of thinking about proteins. We've uncovered Nature's hidden rules to build Natural Machines. With our partners, we are changing the world.
- Adela — Adela is focused on the detection of cancer and other high-morbidity, high-mortality conditions through a blood test.
- Iambic Therapeutics — Iambic has created a cutting-edge AI-driven platform to tackle the most challenging design problems in drug discovery and address unmet patient need.
Arkin Holdings is dedicated to empowering companies that create breakthrough pharma, biotech, medical device, and digital health technologies. Our synergistic healthcare investments are focused on creating innovations that benefit humanity and enhance medical care. We offer extensive experience, with a track record of successful healthcareinvestments. Experts in the dynamic world of healthcare development, we provide the know-how and close accompaniment that helps our portfolio investments achieve substantial value and growth. Arkin Holdings currently has a healthcare portfolio of $1.5 billion through its 5 investment arms. Its investors include a substantial amount of Israel’s top-tier institutional investors.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Medical Device
- Stage:Series A, Seed
- Geography: Israel, United States, Switzerland
Investor stats
- Total investments: 21
- Round size: Seed $5.5M–$6M; Series A $18M–$20M
- Lead/follow: 33% lead, 67% follow
- Last fund: Likely still investing — fund raised in 2021
Portfolio highlights
- Percepto — Percepto is a developer of autonomous drone technology for inspection and surveillance.Drones hold the potential to disrupt multi-billion dollar industries including energy, security, insurance, agriculture, and more. Drones completely change the way inspection, measurement, surveillance, and deliveries are done today. Still, the main barrier tomaking them a must-have platform is the ability of drones to perform tasks autonomously.The company is at the forefront of redefining how industrial sites and critical infrastructure are holistically inspected and monitored, harnessing remote robotics to autonomously collect, aggregate, and analyze visual data.Leveraging its experience with Percepto Sparrow, the most deployed drone-in-a-box solution on the market, Percepto introduced Percepto AIM (Autonomous Inspection and Monitoring) the first end-to-end autonomous inspection and monitoring platform. Percepto AIM empowers the remote operation center of the future to assess risk, minimize downtime, drive efficiency, increase safety, and reduce operational costs.
- MadeRight — We usher in a new era of sustainable fungi-based materials that deliver excellent performance. The future, as we see it, is a novel industrial chain based on biomaterials.
- Revamp Medical — Revamp medical was founded in 2016 with the goal of resolving one of the most urgent unmet needs in Acute Heart Failure patients. Targeting a market of >1M annual admissions in the US with a direct cost of $65B, Revamp is set to deliver an easily adoptable solution using its patented temporary catheter, Doraya™.Revamp has a seasoned team ofprofessionals with a proven track record in leading multiple med-tech startups.
Hadasit Bio-Holdings Ltd. ("HBL") was founded and floated on the Tel Aviv Stock Exchange (TASE : HDST ) and recently on the OTC (OTCBB : HADSY ) in order to allow public participation in the highly promising field of biotechnology.It serves as a precedent in biotech financing - for the first time, public investment is allowed toparticipate in a holding entity including companies based on IP generated by Israel’s foremost medical research center – Hadassah University Hospital ("HU").In addition to the public holdings (54%) – including major Israeli institutional investors, HBL is held by Hadasit (www.hadasit.co.il) (36%) and Consensus Business Group (http://www.consensusbusiness.com) (10%). The traded stock, as a unique investment vehicle, provides investment exposure to a select cluster of 6 biotech companies - all based on inventions developed and owned by HU.HBL is a publicly traded subsidiary of Hadasit Ltd. – the technology transfer company of the Hadassah University Hospital in Jerusalem, Israel. Hadasit was established for the purpose of promoting and commercializing the intellectual property (IP) and R&D capabilities generated by Hadassah, aimed at finding solutions to problems faced by modern medicine.
Show more...Investment focus
- Industry: Biotechnology, Medical, Health Care
- Stage:Series A, Series B
- Geography: Israel
Investor stats
- Total investments: 9
- Lead/follow: 11% lead, 89% follow
Portfolio highlights
- ProtAb — ProtAb develops therapeutic agents that modulate cytokine regulation, tipping the balance toward anti-inflammatory signaling pathways in the treatment of autoimmune and inflammatory diseases. Its first product, Prozumab, is a monoclonal antibody with a novel mechanism of action. It is currently in late-stage preclinical development for thetreatment of inflammatory bowel disease or IBD, ulcerative colitis or UC, and rheumatoid arthritis or RA. It operates as a subsidiary of Hadasit Bio-Holdings. HBL is a publicly traded subsidiary of Hadasit, the technology transfer company of the Hadassah University Hospital in Jerusalem in Israel.
- KAHR medical — KAHR Medical ("KAHR") is pioneering the development of "third generation biological drugs," a unique class of proprietary fusion-protein molecules with clear and far-reaching advantages. KAHR's technology represents a paradigm shift in protein-based pharmaceuticals that will significantly expand available treatment optionsfor cancer and autoimmune disorders.
- Enlivex Therapeutics — Enlivex is a clinical-stage macrophage reprogramming immunotherapy company that targets diseased macrophages in patients with sepsis. The company develops an autologous and allogeneic drug pipeline for the treatment of autoimmune and inflammatory conditions such as Graft versus Host Disease (GvHD), solid organ transplant rejection, Crohn'sDisease, and other autoimmune and inflammatory disorders.The company's revolutionary approach is to induce immune tolerance by injecting apoptotic cells and facilitating their interaction with dendritic cells activates the body's innate, physiologic mechanism for down-regulating inflammation and autoimmunity.Enlivex is an Israeli-based cell immunotherapy company established in October 2005 by Professor Dror Mevorach, a world-renowned expert on clearance of dying (apoptotic) cells.
Early Stage Investment Fund and Network
Show more...Investment focus
- Industry: Biotechnology, Energy, Manufacturing
- Stage:Seed, Pre-Seed, Angel
- Geography: Turkey, United States, Estonia
Investor stats
- Total investments: 31
- Round size: Seed $67k–$1.4M; Angel $29k–$500k; Pre-Seed $35k–$400k
- Lead/follow: 29% lead, 71% follow
Portfolio highlights
- & New Me — Andnewme is a health platform that serves with the motto "only aesthetics". You can get information about aesthetic treatments and find the doctor you are looking for!
- Biftek — The future of meat starts here. We produce growth medium to make cultured meat affordable.
- Nanomik Biotechnology — Nanomik Biotechnology produces next generation biofungicides that increase the shelf life of fresh fruits and vegetables. Antimicrobial raw materials produced by microorganisms isolated from nature and active molecules obtained from plants are placed in micro-sized biopolymer capsules and applied to fruits. These completely natural microcapsulesadhere to the fruit and open within 24-48 hours and provide protection on the surface. While the biopolymer material forms an edible layer on the fruit, the ingredients in it prevent the growth of molds present in the medium. Unlike chemical fungicides, our products do not cause any harm to human and environment.
aMoon is a leading healthtech & life sciences venture capital firm.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Medical
- Stage:Series A, Series B
- Geography: United States, Israel, United Kingdom
Investor stats
- Total investments: 49
- Round size: Series A $6M–$63M; Series B $30M–$35M
- Lead/follow: 59% lead, 41% follow
- Last fund: May invest from a new fund soon — raised $7.3M in 2019
Portfolio highlights
- Theranica — Theranica is a medical device company that has combined neuromodulation therapy with modern wireless technology to develop proprietary wearable solutions that address various medical conditions and disease states. The noninvasive and therapeutic 'smart' patches are controlled by a smartphone app to allow for personalized, portable, andaffordable care. The patch consists of a proprietary 'smart' chip that delivers electrical pulses to neuro-modulate the sensory nerves under the skin. The first application of the technology is for treatment of migraine headaches.
- Eleos Health — Eleos Health provides automated health tech solutions that accelerate clinicians’ decision-making via an AI-powered Speech-to-Insights system to ensure the provision of personalized and time and cost-effective care.
- Ultima Genomics — Ultima Genomics, Inc is revolutionizing DNA sequencing technology with the UG100 by providing scalability for the $100 genome
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Healthcare innovation wherever it originates.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Medical
- Stage:Series A, Series B, Series C
- Geography: United States, Israel, United Kingdom
Investor stats
- Total investments: 69
- Round size: Series A $5.9M–$65M; Series B $7.5M–$80M; Series C $300k–$70M
- Lead/follow: 23% lead, 77% follow
Portfolio highlights
- Moon Surgical — MastOR is a medical device company developing a surgical robot for laparoscopy assistance. MastOR is an early-stage surgical robotics company whose laparoscopy assistance platform broadens access to minimally-invasive techniques for surgeons and optimizes resource utilization in the operating room.
- ArteraAI — Discover the power of Personalized Precision Medicine & AI Cancer Therapy with ArteraAI. Transforming cancer therapy through innovation.
- Nucleome Therapeutics — Decoding the dark matter of the human genome to deliver first-in-class precision medicinesDiscover More
Impact investing in Israeli technology. ZORA is an impact investing fund investing in early-stage Israeli companies solving global challenges in health, education, economic inclusion and the environment.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Internet
- Stage:Seed, Series A, Convertible Note
- Geography: Israel, United States, United Kingdom
Investor stats
- Total investments: 12
- Round size: Seed $1M–$5.2M; Series A $4M–$6M
- Lead/follow: 0% lead, 100% follow
- Last fund: May invest from a new fund soon — last raise in 2019
Portfolio highlights
- BiotaX — Microbiome Genomic Analysis Cloud Platform | Biotax.co
- EyeControl — EyeControl is a medical technology company specializing in innovative communication solutions. We implement advanced AI-technologies to bridge information barriers, facilitating better care and decision-making in healthcare environments.
- Forsea Foods — Forsea Foods develops cell-cultured seafood through the use of patented organoid technology which allows them to bypass the scaffolding stage of cultivated meat production.
Takeda Ventures, Inc. (TVI) is the corporate investment arm of Takeda Pharmaceutical Company Limited (TPC). TVI was founded in 2001 and invests in current and future areas of interest for TPC. They are based alongside Takeda’s R&D sites in Cambridge, MA, and San Diego, CA. As a strategic investor, TVI aims to provide support and guidance toentrepreneurs and early-stage companies driving concepts through clinical proof of concept. They also strive to forge active, collaborative interactions that result in synergies with Takeda's considerable R&D resources. Their goal is to build a portfolio of strategic investments, with an immediate emphasis on oncology, gastroenterology, neuroscience, and rare diseases.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Therapeutics
- Stage:Series A, Series B
- Geography: United States, United Kingdom, Israel
Investor stats
- Total investments: 95
- Round size: Series A $8M–$43M; Series B $11M–$100M
- Lead/follow: 19% lead, 81% follow
Portfolio highlights
- Cerevance — Cerevance is a developer of novel therapeutics intended to advance new medicines for serious neurological diseases.The company's therapeutics applies it's technology called NETSseq to reveal transcriptional and epigenetic differences between specific cell types in mature human brains, enabling healthcare providers to detect and tackle theearly onset of various neurological diseases.
- OncoResponse — OncoResponse Inc., an immuno-oncology company located in Houston, Texas, has partnered with MD Anderson Cancer Center (MDACC) to deploy a unique and transformational approach to cancer therapeutic monoclonal antibody and target discovery. The company licensed the I-STAR™ platform, developed and validated by Theraclone Sciences of Seattle, tointerrogate the human memory B-cell repertoire of cancer patients who are considered “Elite Responders” to immunotherapy; as such, their own adaptive immune system responded to immunotherapy stimulation in a way that achieved curative or durable responses. From these Elite Responders, OncoResponse is leveraging the human immune system to identify fully human monoclonal antibodies and discover novel targets that will lead to the development of fully human antibody derived therapeutics for the treatment of cancer.
- Larkspur Biosciences — Larkspur's strategy focuses on the particular ways in which tumours hijack the immune system by developing precision immunotherapies for molecularly defined patient groups to overcome the bottlenecks that allow the tumour to subvert the immune system.
Clal Biotechnology Industries is a leading Israeli life sciences investment company traded on the Tel Aviv Stock Exchange (TASE: CBI)
Show more...Investment focus
- Industry: Biotechnology, Health Care, Medical
- Stage:Series A, Series B
- Geography: Israel, United States
Investor stats
- Total investments: 14
- Round size: Series A $4M–$55M
- Lead/follow: 14% lead, 86% follow
Portfolio highlights
- Sight Diagnostics — Combining AI and breakthrough hardware to bring lab-quality CBC results to the doctor's office.
- Cadent Therapeutics — Cadent Therapeutics is a precision neuroscience company developing novel medicines that tune and modulate brain rhythms to restore cognitive and motor function in patients with serious neurological disease. The company leverages its precision neuroscience approach combining target specificity, patient selection, drug design and optimization, andnovel quantitative endpoints to create first-in-class molecules to treat movement and cognitive disorders.It was founded in 2010 and headquartered in Cambridge, Massachusetts.
- Elicio Therapeutics — Elicio ground-breaking Amphiphile technology is engineering potent vaccines and immunotherapies to defeat an array of aggressive cancers.
Accelmed is a venture capital firm that funds private and public medical device companies with significant market potential and proven clinical data.Concentrating on medical device companies that have already reached the revenue stage enables the firm to assist companies in benefiting from its managerial capabilities and financial resources.Together with the management teams of their portfolio companies, the Accelmed can steer the way from the clinical-stage to a profitable business with a clear commercial plan, thereby accelerating the path to a successful exit.In 2009, Mori Arkin and Uri Geiger, the co-founders of Accelmed, established the firm in Herzliya, Tel Aviv.
Show more...Investment focus
- Industry: Health Care, Medical Device, Medical
- Stage:Series D, Series A
- Geography: Israel, United States
Investor stats
- Total investments: 34
- Round size: Series A $695k–$24M; Series D $13M–$96M
- Lead/follow: 47% lead, 53% follow
- Last fund: May invest from a new fund soon — last raise in 2019
Portfolio highlights
- Revamp Medical — Revamp medical was founded in 2016 with the goal of resolving one of the most urgent unmet needs in Acute Heart Failure patients. Targeting a market of >1M annual admissions in the US with a direct cost of $65B, Revamp is set to deliver an easily adoptable solution using its patented temporary catheter, Doraya™.Revamp has a seasoned team ofprofessionals with a proven track record in leading multiple med-tech startups.
- Minerva Surgical — Minerva Surgical develops minimally invasive devices to treat the root causes of Abnormal Uterine Bleeding.
- Click Therapeutics — A biotechnology company that develops, validates, and commercializes software as prescription medical treatments for people with unmet medical needs. Learn more.
Our expert team is the first to examine and evaluate the Hebrew University's biomedical breakthroughs. We then capitalize decades of experience - transforming the inventions into pioneering companies. Our golden eggs Ayana Pharma A late stage company with
Show more...Investment focus
- Industry: Biotechnology, Pharmaceutical, Life Science
- Stage:Seed, Series B, Series F
- Geography: Israel
Investor stats
- Total investments: 8
- Lead/follow: 75% lead, 25% follow
Portfolio highlights
- BacoCure — BacoCure is developing a novel bacterial product for local therapy of non-muscle invasive bladder cancer (NMIBC) patients.
- Splisense — Splisense is develops antisense oligonucleotide based therapies to target genetic diseases caused by splicing mutations. The company has developed a compound to cure the lung disease in cystic fibrosis patients carrying a specific splicing mutation. It is also developing a targeted modulation approach to correct the splicing pattern of CFTRtranscripts according to the specific mutation carried.
- Rebiotic Rx — Develops nanotechnology-based antibiotics with the focus on resistant bacteria
Egypt Ventures is an investment firm that empowers the entrepreneurial ecosystem by investing in accelerators. The firm was founded in 2017 and is based in Columbia.
Show more...Investment focus
- Industry: Software, Information Technology, E-Commerce
- Stage:Seed, Pre-Seed, Series A
- Geography: Egypt, United States, The Netherlands
Investor stats
- Total investments: 20
- Round size: Seed $100k–$3M; Pre-Seed $28k–$2M
- Lead/follow: 40% lead, 60% follow
Portfolio highlights
- MNT-Halan — MNT-Halan is a microfinance lending and payments company.
- Gahez Market — Gahez Market Online store
- Synapse Analytics — We build data science and AI solutions for streamlined operations and data driven decisions. Synapse Analytics, enabling a smarter world.
iAngels is a VC and angel investment platform that leverages due diligence and analytics to enable accredited investors around the world the ability to invest in early-stage technology deals in Israel.
Show more...Investment focus
- Industry: Artificial Intelligence, Software, FinTech
- Stage:Seed, Series A
- Geography: United States, Israel, United Kingdom
Investor stats
- Total investments: 108
- Round size: Seed $900k–$10M; Series A $3.5M–$15M
- Lead/follow: 8% lead, 92% follow
- Last fund: Likely still investing — raised $56M in 2021
Portfolio highlights
- Guardz — Ultimate cybersecurity solution built for MSPs, IT pros, & business owners. Protect your clients & business with an all-in-one security & monitoring solution.
- CoinScan — Fastest trading history in the industry for any ETH token along with seeing pending transactions. One-of-a-kind Airdrops and Holders distribution for quick analysis and much more.
- Nest Genomics (YC W22) — Nest Genomics is a lab-agnostic, comprehensive software solution for implementing genomic programs at scale.
Diffusion Capital Partners (DCP) is Turkey's leading Venture Capital fund manager with a focus on deep-tech opportunities.
Show more...Investment focus
- Industry: Software, Information Technology, Biotechnology
- Stage:Seed, Series A
- Geography: Turkey, United States, United Kingdom
Investor stats
- Total investments: 36
- Round size: Seed $375k–$3.4M; Series A $985k–$2.5M
- Lead/follow: 71% lead, 29% follow
- Last fund: May invest from a new fund soon — last raise in 2020
Portfolio highlights
- Khenda — Khenda is an AI-based video analytics platform that helps manufacturing plants to increase their safety, efficiency, and quality at production lines by analyzing manual activities.
- TAZI AI — TAZI's Automated Machine Learning is understandable continuous machine learning from data and humans, enables business domain experts to use machine learning to ...
- Enhencer — Reach AI based transparent audiences or lookaliles for your ecommerce. Achieve higher campaign conversion and ROAS than ever before.
The Office of the Chief Scientist [OCS] in the Ministry of Economy is charged with execution of government policy for support of industrial R&D. The goal of the OCS is to assist in the development of technology in Israel as a means of fostering economic growth, encouraging technological innovation and entrepreneurship, leveraging Israel’sscientific potential, enhancing the knowledge base of industry in Israel, stimulating high value-added R&D and encouraging R&D collaboration both nationally and internationally. A variety of ongoing support programs developed and offered by the OCS play a major role in enabling Israel to be a key center for high tech entrepreneurship.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Hardware
- Stage:Seed
- Geography: Israel
Investor stats
- Total investments: 3
- Round size: Seed $1M–$1M
- Lead/follow: 33% lead, 67% follow
Portfolio highlights
- LapSpace — LapSpace Medical was founded in 2011. It operates within the framework of the Misgav Venture Accelerator, part of The Trendines Group. The LapSpace team combines strong business and medical experience and knowledge.
- Digma Medical — Digma Medical | DiaGone - safe, one-time, 30 minute, minimaly-invasive, GI procedure for Restoring Glycemic Control for T2DM & NASH patients | No Implant
- Immunovative Therapies — Immunovative Therapies is a biopharmaceutical company with financial support of the Israel Office of the Chief Scientist. ITL is a graduate of the Misgav Venture Accelerator, a member of the world renown Israel technological incubator program. The company was the Misgav Venture Accelerator's candidate for the prize for the outstandingincubator project of 2006, awarded by the Office of the Chief Scientist. They specialize in the development of novel immunotherapy drug products that incorporate living immune cells as the active ingredients for the treatment of cancer and infectious disease.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Binder & Partners Ventures is the investments' capital arm of Binder & Partners multi-family office. The ambition of BPV is to connect our investors with the most promising startup companies.
Show more...Investment focus
- Industry: Software, Information Technology, Health Care
- Stage:Seed, Pre-Seed, Series A
- Geography: Israel, France, United States
Investor stats
- Total investments: 14
- Lead/follow: no public data
Portfolio highlights
- Rookout — Speed up the debugging process and accelerate your team's velocity with Rookout's live, remote debugging platform. Debug anything, anywhere. Effortlessly.
- Lumen — Lumen is a device and app that measures your metabolism in a single breath and provides daily personalized nutrition based on your metabolic data. Through the device and app, you can achieve your fitness goals whether they be weight loss, performance optimization, or simply improving your metabolic health.As a company, we are a team ofscientists, researchers, engineers, and designers, aimed at improving the way people understand their metabolism. We believe that a healthy metabolism is a key to better health and that everyone can attain it with a little help from Lumen.At Lumen, we are all about teamwork, friendship, and family. Curious about joining? We are always looking for creative people who share our passion for health and fitness to join our team.
- Blink Technologies — Blink creates the ultimate interaction between your eyes & the world around you with our eye tracking software & eye tracking technology.
FutuRx is the Israeli biotechnology accelerator that was established in 2014 by OrbiMed Israel Partners, Johnson & Johnson Innovation and Johnson & Johnson Development Corporation (JJDC) and Takeda Ventures Inc. following winning the tender of the Office of the Chief Scientist (OCS), Ministry of Economy, in Israel.The incubator willadvance new biotechnology products by identifying and nurturing early-stage life science innovation.FutuRx is located in the Weizmann Science Park in Ness Ziona (near the Weizmann Institute), Israel.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Pharmaceutical
- Geography: Israel
Investor stats
- Total investments: 3
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Ramino Bio — Ramino Bio is a private biotech company that develops an oral drug to treat metabolic diseases.Ramino has received funding totaling about $3.3 million since its beginning from the FutuRx biotech incubator, which is supported by the Israeli Innovation Authority, Takeda, J&J, OrbiMed, and RMPG. By speeding up their disintegration, our exclusivetechnology lowers the extra BCAA that is floating around.
- Protekt Therapeutics — ProteKt Therapeutics is a drug development company aiming to develop potent and selective oral inhibitors of the kinase PKR for the treatment of neurodegenerative and neuroinflammatory diseases. The company has raised a $4M pre-A round and graduated from the FutuRx accelerator in 2019.
- Bsense Bio Therapeutics — Bsense Bio Therapeutics is developing small molecules for the treatment of neuropathic pain. Bsense is pioneering a novel approach targeting multiple pain-related mechanisms using a single compound, to achieve greater efficacy and safety.
ZMEP is a limited partnership focusing on equity and equity-like investments in emerging medical device technologies. ZMEP invests globally drawing on the years of investing experience of its management team. With over 50 years of experience in medical device development and commercialization, the ZMEP management team has the ability to seek outand partner with leading entrepreneurs in the medical device field. With offices in the United States and Israel, ZMEP is positioned globally to partner with middle to late stage medical device companies showing great promise for success through commercialization.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Mobile
- Stage:Series C, Series E, Series F
- Geography: United States, Israel
Investor stats
- Total investments: 6
- Lead/follow: 33% lead, 67% follow
Portfolio highlights
- Aposense — Aposense (formerly NST) is a clinical-stage molecular imaging and drug development company, with a pipeline of products based on its patented platform technology for targeting apoptosis (programmed cell death) in vivo. The company translating the science of Apoptosis (programmed cell death) into personalized patient care in multiple diseasecategories, including oncology, cardiology, and neurology. Targeting of this important biological process in-vivo opens opportunities for real-time clinical imaging of disease activity and targeted therapy.Aposense specializing in the development of novel drugs and utilizing membrane electrical forces for trans-membrane of macromolecule drugs, mainly siRNA. It also developed rationally-designed molecular nano-motors (MNMs), being novel small-molecule chemical entities and its translation into kinetic energy for movement within the hydrophobic membrane core.Aposense was founded in 1996 and is headquartered in Petah Tiqva, HaMerkaz, Israel.
- MAKO Surgical — MAKO Surgical is a medical device company, markets its advanced robotic arm solution, joint specific applications for the knee and hip, and orthopedic implants for orthopedic procedures in the United States and internationally. The company offers MAKOplasty, a restorative surgical solution that enables orthopedic surgeons to treat patient specificosteoarthritic disease. It also provides robotic arm interactive orthopedic system (RIO) consisting of a tactile robotic arm utilizing an integrated bone cutting instrument; and a patient specific visualization component, which offers pre-operative and intra-operative guidance to the orthopedic surgeon, enabling tissue sparing bone removal, and accurate implant insertion and alignment.In 2011, The company was named the No.1 on the Technology Fast 500 as the fastest growing technology company by Deloitte and received the CSSEC Award for loyal, customer-focused staff members presented by the Technology Services Industry Association and ACE Award (Achievement in Customer Excellence) from MarketTools and Fast Tech Award as one of the 25 fastest growing technology companies in South Florida by South Florida Business Journal.MAKO Surgical was founded in 2004 and is headquartered in Florida, USA.
- MobileAccess Networks — Corning Everon Network Solutions offer in-building cellular solutions to meet a broad array of design scenarios and mitigate RF propagation challenges.
Welltech Ventures is Israel’s leading fund focused exclusively on investing in the health and wellness space. We seek to partner with entrepreneurs who epitomize the Startup Nation’s ethos and are building paradigm-shattering companies that are making an impact in the wellness space. As thought leaders we work with global investors focused onaccessing and investing in the Israeli tech ecosystem’s most promising entrepreneurs.
Show more...Investment focus
- Industry: mHealth, Health Care, Biotechnology
- Stage:Seed, Pre-Seed
- Geography: Israel, United States
Investor stats
- Total investments: 10
- Round size: Seed $1.9M–$19M
- Lead/follow: 50% lead, 50% follow
Portfolio highlights
- Behavidence — Behavidence is a mental health application that generates a daily mental health score. It compares your digital behavior to other people with anxiety, depression and ADHD.
- AMKIRI — Amkiri has scientifically developed a Brand New product category for the beauty industry which combines the senses of smell and sight, and enables the complete freedom of multi-sensory self-expression.
- Quris — Quris Technologies is an artificial intelligence (AI) innovator disrupting the pharmaceutical arena.
Neo Ventures is the first open-ended early stage investor, based in Eastern Europe. The founders have backed more than 30 startups and exited 10 successfully. We invest in game-changing businesses, without geographic limitations. We partner with exceptional founder teams to challenge incumbents in markets ripe for change or to create entirely newmarkets. Neo Ventures funds and then supports the founders in business planning, scaling operations, follow-on investments, making the best of each opportunity and dealing with hard situations. Our investment focus is on data analytics, computer vision and remote sensing addressing disruptive opportunities across the high-growth SpaceTech, BioTech and Security verticals.
Show more...Investment focus
- Industry: Software, Artificial Intelligence, Aerospace
- Stage:Seed, Series A
- Geography: Israel, United Kingdom, Estonia
Investor stats
- Total investments: 13
- Round size: Seed $1.1M–$1.6M
- Lead/follow: 31% lead, 69% follow
Portfolio highlights
- EnduroSat — EnduroSat designs, builds and operates class-leading NanoSats for a range of commercial, exploration and science missions. We focus on inter-satellite connectivity and space data applications
- Cyberwrite — TRUSTED BY INDUSTRY LEADERS One platform to accelerate value across the cyber insurance lifecycle THE LATEST FROM CYBERWRITE
- GemmaCert — The easy-to-use GC-PRO by GemmaCert for quick and accurate potency analysis of cannabis and hemp, including for THC, CBD, and CBG.
Millennium Food-Tech is an R&D partnership traded on the Tel Aviv Stock Exchange that specializes in investment in and betterment of companies in food-tech sectors,. Millennium seeks to invest in companies that specialize in identifying and developing innovative, and transformative ideas in the food, drinks, and nutrition industry. Millenniumhas experienced management, proven solutions, and a supportive network to develop ideas and start-ups from early-stage to maturity to exit.
Show more...Investment focus
- Industry: Food and Beverage, Manufacturing, Agriculture
- Stage:Seed, Series A, Convertible Note
- Geography: Israel
Investor stats
- Total investments: 13
- Round size: Seed $2.5M–$4.1M; Convertible Note $4M–$10M
- Lead/follow: 79% lead, 21% follow
Portfolio highlights
- Tipa — Tipa has developed breakthrough 100% biodegradable and compostable flexible packaging solutions for food and beverages. Imitating nature’s and just like an orange peel, their packaging solutions bring a new generation of packaging that easily biodegrade post-consumption and reduce dramatically their impact on the environment.Ranging from simpleone-ply films to complex multi-layer products, their packaging solutions offer a combination of superior properties in almost every aspect including high yield, flexibility, transparency, impact strength, and barrier properties.
- Phytolon — Phytolon revolutionizes the way food colors are produce, by Leveraging a novel and sustainable technology for production of healthy food colors in high quality at low costs. Phytolon's mission is to exploit scientific advancement promote human health and environmental sustainability
- Supersmart — Supersmart is the world's leading loss-prevention solution for self-scan transactions. Supersmart uses its proprietary machine-learning, AI algorithm to validate all self-scanning transactions in physical stores. Our solution enables retailers to confidently provide self-scanning options to their customers, enhancing customer experiencewithout sacrificing potential loss.The Israel-based company was founded in 2014 by Yair Cleper and Amir Ayalon.
Pitango VC is a venture capital firm focused on health-tech (Pitango Health-tech) and growth (Pitango Growth) investments in startups around the world in domains such as vertical SaaS, digital health, deep tech, fintech and insurance technology, devops, generative AI, Web3, and food tech.With two offices in Israel, Pitango currently managesseveral venture funds totaling over $2.8 billion in committed capital. It has invested in more than 250 companies.
Show more...Investment focus
- Industry: Software, Health Care, Information Technology
- Stage:Series A, Series B, Series C
- Geography: Israel, United States, China
Investor stats
- Total investments: 243
- Round size: Series A $2M–$25M; Series B $7M–$35M; Series C $7.5M–$42M
- Lead/follow: 36% lead, 64% follow
- Last fund: Likely still investing — fund raised in 2023
Portfolio highlights
- AI21 Labs — AI21 Labs is an AI lab & product company whose mission is to reimagine the way we read and write by making the machine a thought partner to humans.
- QuantHealth — QuantHealth is an AI company that provides a platform to simulate clinical trials in order to accelerate and de-risk drug development.
- Gina Life — At Nevia bio, we are focused on women's health. Our mission is to use innovative technologies to provide early detection of diseases through vaginal secretions analysis, enabled by Nevia's Machine Learning Platform.
Early stage deep tech investor
Show more...Investment focus
- Industry: Artificial Intelligence, Software, Manufacturing
- Stage:Seed, Convertible Note, Series A
- Geography: Turkey, United States, United Kingdom
Investor stats
- Total investments: 31
- Round size: Seed $321k–$2.7M; Convertible Note $964k–$1.3M
- Lead/follow: 77% lead, 23% follow
- Last fund: May invest from a new fund soon — last raise in 2015
Portfolio highlights
- Hazy — Hazy is a UCL AI spin out backed by Microsoft and Nationwide. Our core product is synthetic data - data generated artificially using machine learning techniques, that retains the statistical properties of the real data and can be safely used for analytics and innovation without compromising customers privacy and confidential information. We do itby capturing patterns in the raw data to generate completely synthetic 'hazy' data that maintains the statistical value of the original. This means businesses can unlock their data for innovation freely with safer and faster data provisioning on demand and no compliance, security or privacy risks and procurement delays.
- 3E Nano — 3E Nano has developed and is commercializing a low cost, thermally and optically smart, Diamond-Like Carbon (DLC) coating. This nano thin film applied to glass and other transparent media is targeted toward windows, windshields, greenhouses, and solar module manufacturers.
- Productive Machines — We create digital twins of the milling process to identify vibrations and then automatically personalize the tool path parameters to eliminate chatter. Our customers get to the best part, faster, the first time.
Early Stage VC
Show more...Investment focus
- Industry: Software, Biotechnology, Machine Learning
- Stage:Seed, Pre-Seed, Series A
- Geography: Israel, United States, United Kingdom
Investor stats
- Total investments: 18
- Round size: Seed $1.3M–$5M
- Lead/follow: 22% lead, 78% follow
Portfolio highlights
- Enzymit — Enzymit's platform technology can build molecular machines that enable never before seen chemistry aiming to solve humanity's greatest challenges
- DeepCure — Pioneering a new frontier in drug development. DeepCure is building an AI engine for small-molecule drug discovery.
- Genetika+ — Genetika+ is revolutionzing depression treatment. Using biological, medical and genetic data, GenetikaPlus develops personalized solution for every patient to help them recover better, faster.
S2G Ventures is is a multi-stage venture fund investing in food and agriculture. We're harnessing the power of food innovation to create better outcomes for people and the planet.
Show more...Investment focus
- Industry: Food and Beverage, Agriculture, Biotechnology
- Stage:Series A, Series B, Seed
- Geography: United States, Canada, Israel
Investor stats
- Total investments: 143
- Round size: Seed $250k–$27M; Series A $4.3M–$89M; Series B $3.5M–$45M
- Lead/follow: 41% lead, 59% follow
- Last fund: Likely still investing — fund raised in 2023
Portfolio highlights
- MEND — Mend is the scientifically proven way to heal and enhance your body faster.
- TechMet — TechMet Ltd backs world-class teams and makes direct investments into companies and assets across the value chain.
- Electric Hydrogen — Electric Hydrogen designs and builds low-cost, high-efficiency green hydrogen systems to economically decarbonize industrial sectors like ammonia and steel
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!SciSparc Ltd. is a specialty clinical-stage pharmaceutical company led by an experienced team of senior executives and scientists. Our focus is creating and enhancing a portfolio of technologies and assets based on cannabinoid pharmaceuticals. With this focus, the company is currently engaged in the following drug development programs based ontetrahydrocannabinol (THC) and/or non-psychoactive cannabidiol (CBD): THX-110 for the treatment of Tourette syndrome and for the treatment of obstructive sleep apnea; THX-160 for the treatment of pain; and THX-210 for the treatment of autism spectrum disorder and epilepsy.
Show more...Investment focus
- Industry: Pharmaceutical, Cannabis, Biopharma
- Stage:Corporate Round
- Geography: Israel
Investor stats
- Total investments: 3
- Round size: Corporate Round $400k–$700k
- Lead/follow: 67% lead, 33% follow
Portfolio highlights
- LaraPharm — LaraPharm Ltd. is a group of people joined together by the belief that active components found in the Cannabis plant can provide a real answer to hundreds of types of disease currently not addressed at all, or poorly addressed.
- MitoCareX Bio — MitoCareX Bio is a biotechnology company that focuses on the discovery and development of drugs for cancers & other life-threatening diseases.
Triventures is a global, early stage fund that invests in exceptional entrepreneurs. We partner with disruptive ventures with innovative breakthroughs in healthcare and beyond. Our vision is to create a better, healthier future through data driven solutions and cross industry convergence.
Show more...Investment focus
- Industry: Health Care, Medical Device, Medical
- Stage:Series B, Seed
- Geography: United States, Israel, Ireland
Investor stats
- Total investments: 42
- Round size: Seed $1M–$10M; Series B $6M–$50M
- Lead/follow: 31% lead, 69% follow
- Last fund: May invest from a new fund soon — last raise in 2015
Portfolio highlights
- FEMSelect — More than half of women over 50 are living with Pelvic Organ Prolapse. Learn about EnPlace, the minimally invasive approach to Pelvic Organ Prolapse.
- Future Family — Our loans for IVF & egg freezing make it easy for you to get started quickly with fertility treatment. Learn more about our Fertility Financing & Loans today!
- Brightside Health — Get anxiety and depression treatment online from licensed psychiatric providers and therapists. No need to wait, start a free consultation online today.
DSM Venturing provides start-up funding, coaching and support for start-up companies that share our purpose of creating brighter lives for all.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Manufacturing
- Stage:Series A, Series B
- Geography: United States, Canada, Israel
Investor stats
- Total investments: 85
- Round size: Series A $2.5M–$23M; Series B $4.1M–$17M
- Lead/follow: 53% lead, 47% follow
- Last fund: May invest from a new fund soon — last raise in 2012
Portfolio highlights
- Vivici — Our mission is to meet the world's growing need for sustainable, nutritious and great tasting animal-free proteins.
- Meatable — Meatable is a food production company that produces real and guilt-free meat. With one cell, they are revolutionizing the meat industry's impact on climate change and animal welfare. At the same time they increase food security, without compromising the culinary experience of eating tasty, real meat. They aim to satisfy the world'sappetite for meat without harming people, animals, and the planet.It was founded in 2018 and is headquartered in Delft, South Holland, The Netherlands.
- Incredo — DouxMatok is a food-tech company. They have developed a proprietary technology that enhances the sweetness of sugars with no after taste - preserving the full "sugar experience" customers are looking for. The enhanced sweetness allows for a significant reduction in the consumption of sugar.The company was incorporated in 2014, and itsR&D center is based in Petach-Tikva, Israel.
Elron Ventures is an early-stage investor committed to turning promising ideas into global industry leaders, with a proven track record of investments and successful M&As worldwide. Elron invests in cyber security and B2B software. Since its establishment in 1962, Elron stands on the forefront of Israeli innovation both as a founder and earlyinvestor in companies across various industries such as Elbit, Medingo, Given Imaging, Cloudyn, Cyber Secdo, and Alcide.
Show more...Investment focus
- Industry: Information Technology, Health Care, Software
- Stage:Series A, Seed
- Geography: Israel, United States, China
Investor stats
- Total investments: 56
- Round size: Seed $600k–$6.5M; Series A $1M–$8M
- Lead/follow: 44% lead, 56% follow
Portfolio highlights
- CyVers — Next-generation blockchain threat prevention- Identifies patterns and anomalies across blockchains in real time for proactive Web3 mitigation.
- Entitle — Control access to your organizational cloud resources without creating bottlenecks or friction while creating a seamless experience for employees.
- Wonder Robotics — We are developing cutting edge technologies that will enable the drone revolution, taking into consideration the completely new regulation that will emerge.
TAL Ventures (TAL) is an Israel based Venture Capital group with deep ties to the Israel high-tech ecosystem.
Show more...Investment focus
- Industry: Software, Machine Learning, Artificial Intelligence
- Stage:Seed, Series A, Series B
- Geography: Israel, United States, Cyprus
Investor stats
- Total investments: 35
- Round size: Seed $2.5M–$15M; Series A $10M–$20M; Series B $35M–$120M
- Lead/follow: 6% lead, 94% follow
Portfolio highlights
- Atly — Skip the hunt. Find the best restaurants, date spots, hiking trails and more through groups of people who share your interests.
- TULU — TULU is a smart platform and amenity services provider to over 10,000 people in 50 buildings across the United States, Europe and Israel. Founded in 2019, TULU provides urban tenants with on-demand access to hundreds of brand name appliances, grocery staples, micro-mobility and entertainment devices, and more. TULU’s IoT-based modular units arecustomized to provide the most necessary and useful items, while leveraging advanced machine learning tools to analyze behavioral patterns, optimize usage, refine inventory, and create a personalized experience for our users. The outcome is a new way of living, encouraging more responsible consumption, reducing the cost of living in the city, and consistent with the trend to smaller and smaller living spaces.
- Cyclops Security — stealth mode.
Venture capital fund investing in female founders and women leaders
Show more...Investment focus
- Industry: Health Care, E-Commerce, Fashion
- Stage:Seed, Series A, Pre-Seed
- Geography: United States, Israel
Investor stats
- Total investments: 39
- Round size: Seed $1M–$4.5M; Pre-Seed $900k–$1.2M; Series A $4M–$9.1M
- Lead/follow: 5% lead, 95% follow
Portfolio highlights
- AVEC — Premium, low sugar mixers made with real juice, real fruit, and all natural ingredients. Low in calorie, high in flavor. Don't compromise what you mix with your spirit.
- Droplette — Finally, a tool to deeply infuse skin with your favorite actives. Let that sink in. Droplette makes ingredients tiny and fast to get under your skin.
- Expressable — Expressable is an online speech therapy practice for everyone with a communication disorder. It has pioneered a parent-focused care model that uses technology and education to integrate speech therapy techniques into children's daily lives, improving outcomes and experiences.The company was founded in 2019 and is headquartered in Austin,Texas.
JJDC, Inc. is the strategic venture capital arm of Johnson & Johnson Innovation. Learn more about our equity investment strategy.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Medical
- Stage:Series A, Series B, Series C
- Geography: United States, Israel, United Kingdom
Investor stats
- Total investments: 71
- Round size: Series A $4.2M–$42M; Series B $5M–$65M; Series C $11M–$103M
- Lead/follow: 24% lead, 76% follow
Portfolio highlights
- Astraveus — Designing and building closed, automated, bioprocessing systems for the production of cell and gene therapies.
- Rapport Therapeutics — Precision medicines to match the complexity of the human brain.
- Perceive Biotherapeutics — Perceive Biotherapeutics is a biotechnology company pioneering novel technologies and therapeutics in ophthalmology.
Genesis Park is a Houston-based private equity firm focusing on buyouts, partnering strategies with public corporations, and growth financing. We bring capital, commercial execution capabilities and a depth of experience in mergers and acquisitions.We are opportunistic within market sectors where we have depth and exposure. Those sectors includetelecommunications, energy technology and media. Energy technology is a rapidly expanding category, and our Houston base allows us to marry traditional and alternative techniques in upstream and downstream environments. Founded in 2000, Genesis Park has used discipline and patience to build value for our investors, regardless of prevailing market conditions. We are consistently active in our portfolio companies, listening, learning and adding value by working alongside management. While our preference is to partner with an existing management team, we commonly source additional talent to optimize the existing opportunity.
Show more...Investment focus
- Industry: Manufacturing, Health Care, Natural Resources
- Stage:Private Equity, Debt Financing
- Geography: United States, Israel
Investor stats
- Total investments: 16
- Round size: Debt Financing $5.5M–$65M; Private Equity $2.5M–$200M
- Lead/follow: 56% lead, 44% follow
- Last fund: Likely still investing — fund raised in 2021
Portfolio highlights
- The Good Feet Store — Good Feet has been helping people with foot problems feel better and get back to living their lives. Personally fit with the arch support that meets their needs. Contact us now to see the available Good Feet Arch Support!
- WESTCO GROUNDS — Westoco Provides Landscaping is a highly competitive industry, and Westco continues to thrive because it tailor services to specific client needs and deliver complete solutions with dependability,Rainbird facilitate quick responses and ressources.
- Le Sueur Incorporated — Le Sueur Incorporated is a mining & metals company offering sand casting, permanent mold, and die casting.
A Private Equity Investment Company Founded by Leon Recanati in 2003, GlenRock leverages a unique combination of private equity, multidisciplinary in-house expertise, unmatched access to quality dealflow, and a focused but flexible investment strategy to achieve maximum returns.
Show more...Investment focus
- Industry: Software, Cyber Security, Medical Device
- Stage:Seed, Series B, Series A
- Geography: Israel, United States
Investor stats
- Total investments: 30
- Round size: Seed $1M–$19M; Series A $1.5M–$9M; Series B $100k–$12M
- Lead/follow: 3% lead, 97% follow
Portfolio highlights
- Cylus — Cylus, the global leader in rail cybersecurity, helps rail, freight and metro companies avoid service disruption and safety incidents by detecting cyber-attacks in their signaling and control networks, wayside and onboard, before harm happens.
- Karamba Security — Karamba Security's patented software detects and prevents cyberattacks on a wide variety of connected devices and systems, including automotive ECUs, Industry 4.0 controllers, enterprise edge devices, and IoT endpoints. Karamba's security solutions are embedded within devices and work automatically, without any need for customer operationand with negligible performance impact.
- Quris — Quris Technologies is an artificial intelligence (AI) innovator disrupting the pharmaceutical arena.
LoftyInc Capital Management empowers Afropreneurs to build a prosperous and equitable future in Africa. We deliver value to both founders and investors.........
Show more...Investment focus
- Industry: FinTech, Financial Services, Software
- Stage:Seed, Pre-Seed, Series A
- Geography: United States, Nigeria, Egypt
Investor stats
- Total investments: 111
- Round size: Seed $100k–$3.2M; Pre-Seed $100k–$2M; Series A $250k–$15M
- Lead/follow: 14% lead, 86% follow
- Last fund: Likely still investing — fund raised in 2021
Portfolio highlights
- Craydel — Get Professional career guidance based on Psychometric Assessments and get scholarships to the best MBA, Engineering, Medical, Education online and on campus courses in Africa and Abroad.
- EMTECH — For Modern Central Banking
- Terragon Group — Terragon is a leading Data and Marketing Technology company that uses data and analytics to help companies focused in Africa, intelligently connect at scale to their customers. We use an aggregation of online and offline data, and predictive scoring to help brands, marketing agencies and platforms accurately target people across channels anddevices. Headquartered in Lagos; Nigeria, we also have a presence in Kenya, South Africa, Ghana and India.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!RMGP Biopharma Investment Fund is an investment Fund
Show more...Investment focus
- Industry: Biotechnology, Health Care, Pharmaceutical
- Stage:Series B
- Geography: Israel
Investor stats
- Total investments: 3
- Lead/follow: no public data
Portfolio highlights
- Ramino Bio — Ramino Bio is a private biotech company that develops an oral drug to treat metabolic diseases.Ramino has received funding totaling about $3.3 million since its beginning from the FutuRx biotech incubator, which is supported by the Israeli Innovation Authority, Takeda, J&J, OrbiMed, and RMPG. By speeding up their disintegration, our exclusivetechnology lowers the extra BCAA that is floating around.
- Pi Therapeutics — Pi Therapeutics is a discovery-stage biopharmaceutical company aiming to develop a novel cancer drug. The company is financed by a syndicate of Takeda Pharmaceutical Company through its venture group Takeda Ventures Inc., Johnson & Johnson Innovation – JJDC, OrbiMed Israel Partners, Pontifax, and the Israel Innovation Authority, and hasoperated since March 2015 in the FutuRx biotech accelerator in Ness Ziona, Israel. The company’s mission is to develop novel first-in-class drugs directed against the ubiquitin-proteasome system (UPS), mainly for treatment of cancer.
- Protekt Therapeutics — ProteKt Therapeutics is a drug development company aiming to develop potent and selective oral inhibitors of the kinase PKR for the treatment of neurodegenerative and neuroinflammatory diseases. The company has raised a $4M pre-A round and graduated from the FutuRx accelerator in 2019.
Flerie is an active long-term life science investor, focusing on biotech and pharmaceutical investments globally.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Medical
- Stage:Series A, Series B
- Geography: Sweden, Israel, Iceland
Investor stats
- Total investments: 13
- Round size: Series A $2.5M–$21M; Series B $12M–$75M
- Lead/follow: 38% lead, 62% follow
Portfolio highlights
- AnaCardio — AnaCardio develops drugs targeting a novel mechanism that improves cardiac contractility and aims to improve clinical outcomes in heart failure.
- XNK Therapeutics — XNK Therapeutics, founded in 2012, is one of the pioneering companies within the landscape of cell therapy.
- Vitara Biomedical — Vitara Biomedical has developed a therapeutic platform to support premature infants. Vitara Biomedical's platform was inspired by natural physiological processes to transform neonatal care.
Morris Kahn bussiness in Aurum Ventures MKI and The Kahn Foundation an independent private philanthropic foundation.
Show more...Investment focus
- Industry: Biotechnology, Medical Device, Information Technology
- Stage:Seed, Series A, Series C
- Geography: Israel
Investor stats
- Total investments: 6
- Lead/follow: 17% lead, 83% follow
Portfolio highlights
- Nucleix — OUR TESTS AIM TO DETECT CANCER EARLIER - WHEN TREATMENT CAN BE MOST EFFECTIVE FOR PATIENTS OUR PRODUCTS
- Scopio Labs — Click here to learn more about Scopio Labs AI Driven Digital Platform for Cell Morphology.
- KidneyCure — KidneyCure offers a novel dimension to treating advanced Chronic Kidney Disease.
Since the firm was founded in 1994, Jerusalem Global's goal has been to support private Israeli technology initiatives and to generate superior returns to investors. Over the last two decades, the partners of Jerusalem Global Ventures have developed strong ties with the top Israeli entrepreneurs and visionaries enabling JGV to invest in thebest of Israel's entrepreneurs and help their portfolio companies build winning management teams.
Show more...Investment focus
- Industry: Software, Information Technology, Biotechnology
- Stage:Series A, Series B, Series C
- Geography: United States, Israel, Canada
Investor stats
- Total investments: 29
- Round size: Series A $2M–$20M; Series B $6M–$14M; Series C $5.8M–$56M
- Lead/follow: 28% lead, 72% follow
Portfolio highlights
- Moovit — Utilizing the power of MaaS, we're helping cities, transit agencies and corporations simplify urban mobility, making it more efficient, accessible and sustainable.
- Quiet Therapeutics — Quiet Therapeutics is an emerging biotech company founded in 2010 developing a proprietary nanoparticle-based delivery system (gagomers) focused on oncology and inflammation.Based on the targeting capability of our innovative technology, the company is well positioned to expand the drug target repertoire in cancer and inflammation. The Gagomerdelivery approach enables us to target cell components that are not manageable by other therapeutic agents like small molecules or antibodies.
- SolarEdge Technologies — Turn your businesses and homes into a sustainable energy hub with a SolarEdge inverter solution and the SolarEdge energy manager platform.
NFX Bio is a fund initiative that seeks to invest in scientist-founders at the seed stage with a technology platform approach.Led by Omri Amirav Drory, a venture partner with NFX, who founded Genome Compiler, it helps scientists learn to be founders and guides biology companies with information technology to be a critical distinction with massiveimplications.
Show more...Investment focus
- Industry: Biotechnology, Therapeutics, Medical
- Stage:Seed
- Geography: Israel
Investor stats
- Total investments: 2
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Eleven Therapeutics — Harnessing the power of combinatorial chemistry and AI to transform RNAi drug development into a programmable process.
- Pangea Therapeutics Ltd. — Pangea provides services to Pharma/Biotech companies based on its proprietary platform.
OTV focuses on round A+ startups that aim to make a significant impact on people's lives. Our focus is on entrepreneurs with innovative ideas who are advancing the global state of well-being. Come join the digital health revolution, and be a part of transforming the healthcare industry.
Show more...Investment focus
- Industry: Health Care, Medical, Artificial Intelligence
- Stage:Series A, Series B, Seed
- Geography: United States, Israel, Ghana
Investor stats
- Total investments: 21
- Round size: Seed $5M–$8M; Series B $16M–$50M
- Lead/follow: 57% lead, 43% follow
- Last fund: May invest from a new fund soon — last raise in 2020
Portfolio highlights
- Scopio — Buy & sell images on the largest Solana Photography NFT Marketplace. Find high-quality stock images & hire artists from around the world.
- Scopio Labs — Click here to learn more about Scopio Labs AI Driven Digital Platform for Cell Morphology.
- Stake — Renters earn Cash back for rent. Building operators outperform the market. That's the Stake win-win. Find out how we're building the financial tools for the next generation of rentals.
Cairo Angels is an angel investment network that invests in and supports early-stage startups it convenes regular investment meetings to review pre-selected potential investees.
Show more...Investment focus
- Industry: E-Commerce, Mobile, Marketplace
- Stage:Seed, Angel, Pre-Seed
- Geography: Egypt, United States, Lebanon
Investor stats
- Total investments: 31
- Round size: Seed $50k–$3M; Angel $200k–$300k
- Lead/follow: 42% lead, 58% follow
Portfolio highlights
- Nawah Scientific — Nawah is MENA & Africa's first Cloud Lab providing Analytical and R&D services to the region's life science, food, agricultural and pharmaceutical sectors.
- Sprints — home page Description
- The Fashion Kingdom — Fashion, Sneakers for men, women, and kids
Endure Capital is an early stage investment fund headed by entrepreneurs looking for startup teams. They look for founders who are relentlessly resourceful and imaginative, solving genuine problems that matter to a lot of people and building high growth companies that endure.
Show more...Investment focus
- Industry: Health Care, Software, E-Commerce
- Stage:Seed, Series A, Series B
- Geography: Egypt, United States, United Kingdom
Investor stats
- Total investments: 59
- Round size: Seed $225k–$6.4M; Series A $1M–$34M; Series B $6M–$14M
- Lead/follow: 27% lead, 73% follow
- Last fund: Likely still investing — raised $50M in 2022
Portfolio highlights
- Suplyd — Suplyd is a comprehensive digital solution that bridges the gap between restaurant operators and their suppliers in order to disrupt an untouched market with extreme fragmentation and resolve the problem end-to-end.
- Pylon — Pylon provides water and electricity distribution companies, in emerging markets, with a platform for managing their customers and infrastructure.
- Almentor — almentor.net is a cutting-edge continuous e-learning platform curating top-rated video-based training programs delivered by leading subject matter experts and accessible through B2C and B2B channels to serve the needs of Arabs across the world. The platform was officially launched in January 2018 and currently offers the biggest Arabic high qualitycontinuous learning video library in the world, including paid courses, free talks, crash courses and books, primarily in Arabic.
Merck Ventures is the strategic, corporate venture capital arm of Merck. Its mandate is to invest in innovative technologies and products with the potential to significantly impact Merck‘s core business areas. From its headquarters in Amsterdam and offices in the US and Israel we invest globally in transformational ideas driven by greatentrepreneurs. Merck Ventures takes an active role in its portfolio companies and teams up with entrepreneurs and co-investors to translate innovation towards commercial success. Merck Ventures has a significant focus on early-stage investing and company creation including the creation of spin-offs to leverage Merck‘s science and technology base.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Therapeutics
- Stage:Series A, Series B, Seed
- Geography: United States, Switzerland, United Kingdom
Investor stats
- Total investments: 115
- Round size: Seed $2.1M–$18M; Series A $6M–$42M; Series B $9.5M–$67M
- Lead/follow: 39% lead, 61% follow
Portfolio highlights
- Astraveus — Designing and building closed, automated, bioprocessing systems for the production of cell and gene therapies.
- Anavo Therapeutics — UNLOCKING THE PHOSPHATASE TARGET CLASS: Anavo Therapeutics is the first company to systematically drug phosphatases, a rich target space previously considered undruggable for decades.
- Celestial AI — We develop audacious AI computing platforms that elevate performance, energy and economic efficiencies, enabling our customers to rapidly deploy innovations in their AI applications.
We are an early stage venture capital fund passionate about helping entrepreneurs bring innovative solutions to market.
Show more...Investment focus
- Industry: Software, Information Technology, SaaS
- Stage:Seed, Series A
- Geography: United States, Israel, Australia
Investor stats
- Total investments: 49
- Round size: Seed $1M–$5.6M; Series A $2M–$6.5M
- Lead/follow: 27% lead, 73% follow
- Last fund: May invest from a new fund soon — raised $40M in 2019
Portfolio highlights
- qbiq — qbiq develops cutting-edge Artificial Intelligence, Generative Design, and Optimization Technologies to real-estate planning.With a click of a button, hundreds of cloud processors, loaded with thousands of years of architectural experience, process your planning request, analyze different layout alternatives, and optimize the results. In justseconds, we provide you with the best construction alternatives considering utilization, costs, build time, efficiency, and more.
- 1touch.io — By continuously analyzing traffic and repository stores connected to your network, our network-based solution can detect all elements on the network that are storing, processing, and sharing personal data, both internally and externally. Whether structured or unstructured data, data in motion or at rest, and even data that is unknown to you,1touch.io can track it for you.
- Intracare Health Services — Intracare is a tech-enabled provider of complex drug and biologic infusion therapy coordinated under the supervision of a provider.
FAQ
Is Shizune data fresh/accurate?
Shizune has monitored hundreds of funding sources since 2020.
Our investor database is updated every day, so investor data is always fresh.
All metrics are calculated from confirmed public rounds, so the data is accurate.
Can I download investor list?
To download the Biotechnology VC Funds in Middle East investor list, create a Shizune account. This investor list will be added to your saved investors and available for download in the export section.
You can also enrich the investor list with investor emails, phones, LinkedIns, and other contact data.
Can I access investor database?
To access all 48,091 VC funds investing in Middle East Biotechnology startups and 48,091+ more investors, create a Shizune account.
Shizune has a database of 48,091 investors. Our investor database is fresh and updated daily.
The Shizune investor database has information on investor investment focus, investor contact data, and full investor portfolio since 2020.
You can enrich with email and download the data.
Does Shizune have investor emails and contacts?
Shizune enriches investors with contact data that includes: email, phones, LinkedIn, socials, website, and others.
To guarantee the highest discovery rate, we search across 20+ contact search tools.
To maximize delivery rate and reduce bounce rate, we validate emails.
You can enrich your investor list with Shizune. Download it too.
What is Shizune?
Shizune is a 48,091 investor database updated daily.
With Shizune you can:
- browse the database
- use smart matching
- enrich with emails
- download
All you need to find investors for your startup.
Who is Shizune for?
Shizune is built for startup founders by startup founders.
If you are looking for funding for your startup, try the Shizune database — we have investors for every stage, industry, and country.
Is Shizune free?
Shizune is free forever. You can search and browse investors for free.
Email search and export are paid features.
For full info, visit our pricing.
Who built Shizune?
Shizune is built by founders with the goal of helping all founders raise funding no matter where they are.
Contact 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!